ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651654 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651654; 2) Community: the network communities that were significantly associated with the response to NSC 651654; 3) Molecule: the relationships between components within communities and NSC 651654; 4) MDR: the compounds that were significantly associated with the NSC 651654.

NSC Compound Enrichment Correlation
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.0241085022307781 0.55882103
NSC 641177 Null 0.0241085022307781 0.53668562
NSC 641233 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- 0.0241085022307781 0.1831836
NSC 641297 ANTINEOPLASTIC-641297 0.0241085022307781 0.30517814
NSC 645159 Null 0.0241085022307781 0.56070297
NSC 645808 Null 0.0241085022307781 0.29254808
NSC 114346 Null 0.0247979034812109 0.30380052
NSC 119915 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)propanoic acid 0.0247979034812109 0.39034149
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0247979034812109 0.39993786
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0247979034812109 0.33378003
Total:104  Current:59    [First] [Prev] [Next] [Last]